Literature DB >> 28315845

ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson's disease.

Angelo Antonini1, Paolo Barone2, Ubaldo Bonuccelli3, Karin Annoni4, Mahnaz Asgharnejad5, Paolo Stanzione6.   

Abstract

BACKGROUND: Impulse control disorders/other compulsive behaviours ('ICD behaviours') occur in Parkinson's disease (PD), but prospective studies are scarce, and prevalence and clinical characteristics of patients are insufficiently defined.
OBJECTIVES: To assess the presence of ICD behaviours over a 2-year period, and evaluate patients' clinical characteristics.
METHODS: A prospective, non-interventional, multicentre study (ICARUS (Impulse Control disorders And the association of neuRopsychiatric symptoms, cognition and qUality of life in ParkinSon disease); SP0990) in treated Italian PD outpatients. Study visits: baseline, year 1, year 2. Surrogate primary variable: presence of ICD behaviours and five ICD subtypes assessed by modified Minnesota Impulsive Disorder Interview (mMIDI).
RESULTS: 1069/1095 (97.6%) patients comprised the Full Analysis Set. Point prevalence of ICD behaviours (mMIDI; primary analysis) was stable across visits: 28.6% (306/1069) at baseline, 29.3% (292/995) at year 1, 26.5% (245/925) at year 2. The most prevalent subtype was compulsive eating, followed by punding, compulsive sexual behaviour, gambling and buying disorder. Patients who were ICD positive at baseline were more likely to be male, younger, younger at PD onset, have longer disease duration, more severe non-motor symptoms (including mood and sexual function), depressive symptoms, sleep impairment and poorer PD-related quality of life. However, they did not differ from the ICD-negative patients in their severity of PD functional disability, motor performance and cognitive function.
CONCLUSIONS: Prevalence of ICD behaviours was relatively stable across the 2-year observational period. ICD-positive patients had more severe depression, poorer sleep quality and reduced quality of life. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  impulse control disorders; non-interventional study; Parkinson’s disease; prospective study

Mesh:

Year:  2017        PMID: 28315845     DOI: 10.1136/jnnp-2016-315277

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  42 in total

1.  Longitudinal analysis of impulse control disorders in Parkinson disease.

Authors:  Jean-Christophe Corvol; Fanny Artaud; Florence Cormier-Dequaire; Olivier Rascol; Franck Durif; Pascal Derkinderen; Ana-Raquel Marques; Frédéric Bourdain; Jean-Philippe Brandel; Fernando Pico; Lucette Lacomblez; Cecilia Bonnet; Christine Brefel-Courbon; Fabienne Ory-Magne; David Grabli; Stephan Klebe; Graziella Mangone; Hana You; Valérie Mesnage; Pei-Chen Lee; Alexis Brice; Marie Vidailhet; Alexis Elbaz
Journal:  Neurology       Date:  2018-06-20       Impact factor: 9.910

Review 2.  Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary: A Report of the AAN Guideline Subcommittee.

Authors:  Tamara Pringsheim; Gregory S Day; Don B Smith; Alex Rae-Grant; Nicole Licking; Melissa J Armstrong; Rob M A de Bie; Emmanuel Roze; Janis M Miyasaki; Robert A Hauser; Alberto J Espay; Justin P Martello; Julie A Gurwell; Lori Billinghurst; Kelly Sullivan; Michael S Fitts; Nicholas Cothros; Deborah A Hall; Miriam Rafferty; Lynn Hagerbrant; Tara Hastings; Mary Dolan O'Brien; Heather Silsbee; Gary Gronseth; Anthony E Lang
Journal:  Neurology       Date:  2021-11-16       Impact factor: 9.910

3.  The mediating effects of depression, anxiety, and rapid eye movement sleep behavior disorder on the association between dopaminergic replacement therapy and impulse control disorders in Parkinson's disease.

Authors:  Sidan Du; Ying Huang; Yifei Ma; Yao Qin; Jing Cui; Wenlin Bai; Hongjuan Han; Rong Zhang; Hongmei Yu
Journal:  Neurol Sci       Date:  2022-10-12       Impact factor: 3.830

4.  Compulsive eating behaviors in Parkinson's disease.

Authors:  Ingrid de Chazeron; Franck Durif; Isabelle Chereau-Boudet; Maria Livia Fantini; Ana Marques; Philippe Derost; Berengere Debilly; Georges Brousse; Yves Boirie; Pierre Michel Llorca
Journal:  Eat Weight Disord       Date:  2019-02-04       Impact factor: 4.652

5.  The Prevalence and Determinants of Neuropsychiatric Symptoms in Late-Stage Parkinsonism.

Authors:  Adrianus L A J Hommel; Marjan J Meinders; Stefan Lorenzl; Richard Dodel; Miguel Coelho; Joaquim J Ferreira; Brice Laurens; Umberto Spampinato; Wassilios Meissner; Kristina Rosqvist; Jonathan Timpka; Per Odin; Michael Wittenberg; Bas R Bloem PhD; Raymond T Koopmans; Anette Schrag
Journal:  Mov Disord Clin Pract       Date:  2020-05-21

6.  Reply: Screening Instruments and Prevalence of Impulse Control Disorders.

Authors:  Paloma Parra-Díaz; Araceli Alonso-Cánovas
Journal:  Mov Disord Clin Pract       Date:  2021-04-19

Review 7.  Does the Country Make a Difference in Impulse Control Disorders? A Systematic Review.

Authors:  Paloma Parra-Díaz; Juan Luis Chico-García; Álvaro Beltrán-Corbellini; Fernando Rodríguez-Jorge; Clara Lastras Fernández-Escandón; Araceli Alonso-Cánovas; Juan Carlos Martínez-Castrillo
Journal:  Mov Disord Clin Pract       Date:  2020-12-21

8.  Bidirectional Correlations Between Dopaminergic Function and Motivation in Parkinson's Disease.

Authors:  Jared T Hinkle; Kelly A Mills; Kate Perepezko; Gregory M Pontone
Journal:  J Geriatr Psychiatry Neurol       Date:  2021-02-24       Impact factor: 2.680

9.  Co-occurrence of apathy and impulse control disorders in Parkinson disease.

Authors:  Bonnie M Scott; Robert S Eisinger; Matthew R Burns; Janine Lopes; Michael S Okun; Aysegul Gunduz; Dawn Bowers
Journal:  Neurology       Date:  2020-10-01       Impact factor: 9.910

Review 10.  Is there a Neurobiological Rationale for the Utility of the Iowa Gambling Task in Parkinson's Disease?

Authors:  Michael F Salvatore; Isabel Soto; Helene Alphonso; Rebecca Cunningham; Rachael James; Vicki A Nejtek
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.